NCT07075471招募中不适用
Real-World Patient Experience of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor (MOVE)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Duration of Vimseltinib Treatment
研究概览
简要总结
The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT.
This study will collect data in an observational disease registry involving no intervention to the participants and will not influence standard medical care or impact treatment decisions for participants.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of TGCT according to medical records
- •Prescribed vimseltinib per the approved label requirements, OR The decision to receive vimseltinib has been made but treatment has not yet been initiated.
- •Has provided informed consent and medical records release
排除标准
- •1. Participant is active in an interventional clinical trial of vimseltinib
结局指标
主要结局
Duration of Vimseltinib Treatment
时间窗: Baseline up to 12 months
Time to Discontinuation of Vimseltinib
时间窗: Baseline to Discontinuation (Estimated up to 12 months)
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in GermanyChronic Heart Failure With Reduced Ejection FractionNCT06486844Bayer500
招募中
不适用
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Multiple SclerosisRelapsing Multiple SclerosisNCT06433752TG Therapeutics, Inc.2,000
已完成
不适用
Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLCT790M Positive NSCLC PatientsNCT03133234AstraZeneca47
已完成
Unknown
A study to determine safety and efficacy of patients receiving colistin.CTRI/2014/03/004485Cipla Ltd100
招募中
不适用
Valuate the Clinical Performance and Safety of da Vinci SP Surgical Systemda Vinci SP Surgical SystemThoracic SurgeryNCT06246617Ruijin Hospital15